|
    4568 Japan: Tokyo

    Daiichi Sankyo Co. Ltd.

    Watchlist
    4568JP
    Closed
    Last Updated: Sep 8, 2023 3:00 p.m. JST Delayed quote

    ¥ 4,155

    28 0.68%
    Previous Close
    ¥4,127
    Advanced Charting
    Volume: 5.1M 65 Day Avg: 4.9M
    104% vs Avg
    4,063 Day Range 4,167
    3,767 52 Week Range 5,162

    Partner Center

    Your Watchlists

    Customize MarketWatch

    Have Watchlists? Log in to see them here or sign up to get started.

    Create Account … or Log In
    Symbol
    Company
    Price
    Chg/Chg %
    (Go to Your Watchlist)
    No Items in Watchlist

    There are currently no items in this Watchlist.

    Add Tickers
    No Saved Watchlists

    Create a list of the investments you want to track.

    Create Watchlist …or learn more
    Uh oh

    Something went wrong while loading Watchlist.

    Go to Watchlist

    Recently Viewed Tickers

    No Recent Tickers

    Visit a quote page and your recently viewed tickers will be displayed here.

    Overview

  • Overview
  • Profile
  • Charts
  • Financials
  • Historical Quotes
  • Premium Tools

    • 4568 Overview

    Key Data

    • Open ¥4,069
    • Day Range 4,063 - 4,167
    • 52 Week Range 3,767 - 5,162
    • Market Cap ¥8.09T
    • Shares Outstanding 2.13B
    • Public Float 1.63B
    • Beta 0.88
    • Rev. per Employee ¥77.373M
    • P/E Ratio 54.10
    • EPS ¥77
    • Yield 0.82%
    • Dividend ¥17
    • Ex-Dividend Date Sep 28, 2023
    • Short Interest N/A
    • % of Float Shorted N/A
    • Average Volume 4.9M

    Performance

    5 Day
    • -3.08%
    1 Month
    • -5.27%
    3 Month
    • -15.36%
    YTD
    • -2.24%
    1 Year
    • -3.12%

    Analyst Ratings

    • Sell
    • Under
    • Hold
    • Over
    • Buy
    Number of Ratings 16 Full Ratings

    Recent News

    Health Care Slips as AstraZeneca Slides -- Health Care Roundup

    Jul. 3, 2023 at 2:18 p.m. ET
    Read full story

    AstraZeneca shares slump after Phase 3 lung cancer drug study

    Jul. 3, 2023 at 8:35 a.m. ET by Steve Goldstein

    AstraZeneca Lung Cancer Treatment Meets Dual Primary Endpoint in First Phase 3 Trial Results

    Jul. 3, 2023 at 7:34 a.m. ET

    AstraZeneca Says Datopotamab Deruxtecan Phase 3 Trial Shows Positive Results in Lung Cancer Patients

    Jul. 3, 2023 at 2:20 a.m. ET

    Esperion’s stock tumbles after disclosing dispute about milestone payment

    Mar. 16, 2023 at 8:21 a.m. ET by Jaimy Lee
    Read full story

    Biotech and Pharma AstraZeneca’s Breast Cancer Drug Beats Expectations, and Other ASCO Highlights

    Jun. 6, 2022 at 9:31 a.m. ET by Barron's
    Read full story

    Biotech and Pharma Why AstraZeneca Could Be a Sound Long-Term Bet

    Feb. 23, 2022 at 4:45 a.m. ET by Barron's
    Read full story

    Biotech and Pharma AstraZeneca Stock Climbs on ‘Groundbreaking’ Breast Cancer Drug Trial Results

    Sep. 20, 2021 at 8:40 a.m. ET by Barron's
    Read full story

    This chart is flashing an S&P warning from a slide for a key metal

    Mar. 29, 2019 at 9:59 a.m. ET by Barbara Kollmeyer
    Read full story

    Hong Kong stocks tip into bear market as gambling shares crumble

    Sep. 11, 2018 at 7:50 a.m. ET by Dow Jones Newswire
    Read full story

    These corporate ties will be on display at Scott Gottlieb’s FDA commissioner confirmation hearing today

    Apr. 5, 2017 at 8:39 a.m. ET by Emma Court

    Daiichi Sankyo Announces 50 Billion Yen Buyback: Why It’s Still Not A Buy

    Jun. 20, 2016 at 10:15 p.m. ET by Barron's

    Japan: How To Invest When Foreigners Are Fleeing

    Apr. 11, 2016 at 10:34 p.m. ET by Barron's

    Sun Pharma recalls Effexor in U.S. for second time

    Antidepressant drug fails in quality test

    Nov. 18, 2014 at 3:32 a.m. ET by Sean Mclain
    Read full story

    Sun Pharma to buy Ranbaxy in $3.2 billion deal

    Apr. 7, 2014 at 1:44 a.m. ET by Sean McLain
    Read full story

    China leads Asia stocks lower

    Sep. 17, 2013 at 6:28 a.m. ET by Daniel Inman
    Read full story

    Hong Kong stocks jump to lead broad Asia gains

    Sep. 2, 2013 at 4:19 a.m. ET by V. Phani Kumar
    Read full story

    Most Asia markets end higher, led by Hong Kong

    Apr. 25, 2013 at 4:24 a.m. ET by V. Phani Kumar
    Read full story

    Hong Kong stocks end off lows; Tokyo sags

    Oct. 3, 2012 at 4:45 a.m. ET by V. Phani Kumar
    Read full story

    Tuesday’s biggest gaining and declining stocks

    Oct. 2, 2012 at 4:53 p.m. ET by MarketWatch

    T. Rowe Price Japan Fund Buys Daiichi Sankyo Co, SoftBank Group Corp, Plaid Inc, Sells Takeda ...

    T. Rowe Price Japan Fund Buys Daiichi Sankyo Co, SoftBank Group Corp, Plaid Inc, Sells Takeda Pharmaceutical Co, Welcia Holdings Co

    Jan. 17, 2022 at 11:38 a.m. ET on GuruFocus.com

    Matthews Japan Fund Buys Yamato Holdings Co, Nissan Chemical Corp, Suntory Beverage & Food, ...

    Matthews Japan Fund Buys Yamato Holdings Co, Nissan Chemical Corp, Suntory Beverage & Food, Sells Fanuc Corp, Advantest Corp, Marui Group Co

    Nov. 1, 2021 at 5:38 p.m. ET on GuruFocus.com

    Daiichi Sankyo Co. Ltd.

    Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. Its products include drugs for the field of oncology such as Trastuzumab deruxtecan, Anti-HER3-ADC, Quizartinib, Milademetan, Valemetostat, Pexidartinib, Edoxaban, Prasugel, and Microgabalin. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.

    Competitors

    Name Chg % Market Cap
    Takeda Pharmaceutical Co. Ltd. 0.02% ¥7.12T
    Chugai Pharmaceutical Co. Ltd. 0.16% ¥7.35T
    Shionogi & Co. Ltd. 0.90% ¥1.92T
    Sumitomo Pharma Co. Ltd. -1.60% ¥208.22B
    Hisamitsu Pharmaceutical Co. Inc. -0.27% ¥404.89B